These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9538648)
1. [Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis]. Kacprzyk F; Chrzanowski W; Kubala L; Orłowski Z Pol Merkur Lekarski; 1997 Feb; 2(8):96-8. PubMed ID: 9538648 [TBL] [Abstract][Full Text] [Related]
2. A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis. Futrakul P Int J Pediatr Nephrol; 1980 Mar; 1(1):18-21. PubMed ID: 7343523 [TBL] [Abstract][Full Text] [Related]
3. Indomethacin treatment of recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation. Kooijmans-Coutinho MF; Tegzess AM; Bruijn JA; Florijn KW; van Es LA; van der Woude FJ Nephrol Dial Transplant; 1993; 8(5):469-73. PubMed ID: 8393556 [No Abstract] [Full Text] [Related]
4. Nephrotic focal segmental glomerulosclerosis in 2004: an update. Meyrier A Nephrol Dial Transplant; 2004 Oct; 19(10):2437-44. PubMed ID: 15280528 [No Abstract] [Full Text] [Related]
10. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Korbet SM Semin Nephrol; 2003 Mar; 23(2):219-28. PubMed ID: 12704582 [TBL] [Abstract][Full Text] [Related]
11. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. Chun MJ; Korbet SM; Schwartz MM; Lewis EJ J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302 [TBL] [Abstract][Full Text] [Related]
12. Nephrotic syndrome resulting from focal segmental glomerulosclerosis in a peripheral blood stem cell transplant patient. Heras M; Saiz A; Sánchez R; Fernandez-Reyes MJ; Mampaso F; Queizán J; Molina A; Vázquez L; Alvarez-Ude F J Nephrol; 2007; 20(4):495-8. PubMed ID: 17879218 [TBL] [Abstract][Full Text] [Related]
13. [Nephrotic syndrome in childhood]. Reusz G; Szabó A; Fekete A Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687 [TBL] [Abstract][Full Text] [Related]
14. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A; Hill GS; Montseny JJ; Meyrier A Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220 [TBL] [Abstract][Full Text] [Related]
15. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Peters HP; van de Kar NC; Wetzels JF Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic focal and segmental glomerulosclerosis in Jamaica. A 10-year review. Barton EN; Williams W; Shah DJ; Miller M West Indian Med J; 1995 Sep; 44(3):85-7. PubMed ID: 8560884 [TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis. Opastirakul S; Chartapisak W J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070 [TBL] [Abstract][Full Text] [Related]
18. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis]. Voznesenskaia TS; Sergeeva TV Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479 [TBL] [Abstract][Full Text] [Related]